Efficiency of low dose aspirin for prevention of complications for in vitro fertilization cycles of the patient with polycystic ovarian syndrome
Phase 2
Completed
- Conditions
- polycystic ovarian syndrome.Polycystic ovarian syndrome
- Registration Number
- IRCT201105216541N1
- Lead Sponsor
- Infertility research center, Shiraz university of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
polycystic ovarian syndrome (PCOS) confirmed by: Hyperandrogenism (clinical and/or biochemical); Ovarian dysfunction (oligo-anovulation and/or polycystic ovaries); The exclusion of other androgen excess or related disorders.
Exclusion criteria: All of the patients with Known hypersensitivity to ASA or previous gastritis or GI bleeding.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of follicles. Timepoint: every 3-4 days. Method of measurement: by Ultra sound scan.;Serum Estradiol. Timepoint: every 3-4 days. Method of measurement: serum level of Estradiol.
- Secondary Outcome Measures
Name Time Method Ovarian size more than 5 cm. Timepoint: 3-4 days. Method of measurement: ultra sound.;Ovarian size more than12 cm. Timepoint: 3-4 days. Method of measurement: ultra sound.